Nautilus Biotechnology (NAUT) Liabilities and Shareholders Equity (2020 - 2026)
Nautilus Biotechnology (NAUT) reported Liabilities and Shareholders Equity of $163.58 million for Q2 2026, down 23.3% from $213.19 million a year earlier and down 8.0% from the prior quarter.
Powered by 
Analysis
Nautilus Biotechnology (NAUT) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Nautilus Biotechnology posted Liabilities and Shareholders Equity of $191.11 million, down 21.3% from FY2024.
- Liabilities and Shareholders Equity has declined for four consecutive years, though with a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $242.74 million in FY2024 (-20.6%), $305.57 million in FY2023 (-12.7%), $350.05 million in FY2022 (-12.1%) and $398.45 million in FY2021 (+368.7%).
- The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q1 2021.
- Year over year, Liabilities and Shareholders Equity has now declined in each of the last 17 quarters, with an average decline of 21.4% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 368.7%); the low point was Q2 2026 (a decline of 23.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $177.78 million (Q1 2026), $191.11 million (Q4 2025) and $200.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 20.88 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 13.87 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 50.73 Bn |
| 10 | Nautilus Biotechnology | 180.66 Mn | 180.66 Mn | 175,000.00 | 163.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 163.58 Mn |
| Mar 31, 2026 | 177.78 Mn |
| Dec 31, 2025 | 191.11 Mn |
| Sep 30, 2025 | 200.92 Mn |
| Jun 30, 2025 | 213.19 Mn |
| Mar 31, 2025 | 227.69 Mn |
| Dec 31, 2024 | 242.74 Mn |
| Sep 30, 2024 | 259.70 Mn |
| Jun 30, 2024 | 272.75 Mn |
| Mar 31, 2024 | 288.65 Mn |
| Dec 31, 2023 | 305.57 Mn |
| Sep 30, 2023 | 318.34 Mn |
| Jun 30, 2023 | 330.77 Mn |
| Mar 31, 2023 | 345.88 Mn |
| Dec 31, 2022 | 350.05 Mn |
| Sep 30, 2022 | 359.31 Mn |
| Jun 30, 2022 | 371.71 Mn |
| Mar 31, 2022 | 384.67 Mn |
| Dec 31, 2021 | 398.45 Mn |
| Sep 30, 2021 | 385.35 Mn |
API Access
Nautilus Biotechnology Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NAUT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NAUT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NAUT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();